Table 1.
The demographic, clinical, and laboratory parameters of patients in both groups
| POAF group (n = 14) | No POAF group (n = 32) | P | |
|---|---|---|---|
| Gender male N (%) | 11 (78.6) | 24 (75.0) | 0.80 |
| Age, years X ± SD | 64.2 ± 6.3 | 67.5 ± 9.5 | 0.25 |
| BMI, kg/m2 ± SD | 28.6 ± 3.7 | 29.1 ± 4.5 | 0.72 |
| Diabetes N (%) | 2 (14.3) | 16.0 (50) | 0.02a |
| Hypertension N (%) | 12 (85.7) | 27 (84.4) | 0.91 |
| Previous myocardial infraction N (%) | 5 (35.7) | 10 (31.3) | 0.77 |
| Previous PCI N (%) | 2 (14.3) | 3 (9.4) | 0.62 |
| Stroke N (%) | 2 (14.3) | 0 (0) | 0.18 |
| Paroxysmal AF in history N (%) | 4 (28.6) | 0 (0) | 0.01a |
| Waist, cm ± SD | 100.5 ± 10.5 | 99.1 ± 10.3 | 0.68 |
| GFR < 40, ml/min N (%) | 3 (21.4) | 0 (0) | 0.05a |
| HbA1c, mmol/l ± SD | 6.1 ± 0.6 | 6.3 ± 1.0 | 0.51 |
| Glucose, mg% ± SD | 113.2 ± 47.2 | 119.9 ± 45.8 | 0.66 |
| Insulin, uU/mL ± SD | 16.1 ± 8.6 | 24.2 ± 25.4 | 0.25 |
| CHA2DS2VASc score ± SD | 2.6 ± 1.4 | 2.9 ± 1.1 | 0.51 |
| Betablockers N (%) | 12 (85.7) | 26 (68.4) | 0.71 |
| ACEI N (%) | 9 (64.3) | 15 (46.9) | 0.28 |
| Aortic cross clamp time, minutes±SD | 40.5 ± 11.0 | 42.3 ± 10.6. | 0.61 |
| Cardiopulmonary bypass time, minutes±SD | 78.4 ± 19.2 | 79.0 ± 17.2 | 0.92 |
| COPD N (%) | 0 (0) | 1 (3.1) | 0.67 |
| Stenosis of RCA ≥ 90% N(%) | 8 (57.1) | 12 (37.5) | 0.20 |
| Potassium level, mEq/l ± SD | 4.1 ± 0.4 | 4.2 ± 0.4 | 0.43 |
| Magnesium level, mEq/l ± SD | 2.1 ± 03 | 2,1 ± 0,3 | 0.93 |
ACEI angiotensin-converting-enzyme inhibitor; AF atrial fibrillation; BMI body mass index; CHA2DS2VASc score for atrial fibrillation stroke risk calculator; COPD chronic obstructive pulmonary disease; GFR glomerular filtration rate; HbA1c glycated haemoglobin; POAF Postoperative atrial fibrillation; N number of patients, RCA right coronary artery; X mean value, SD standard deviation
aStatistically significant